Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer

Breast Cancer Research and Treatment

Volumn 134, Issue 1, 2012, Pages 89-100

  Inao, Touko ^a   Harashima, Nanae ^a   Monma, Hiroyuki ^a   Okano, Shinji ^b   Itakura, Masayuki ^a   Tanaka, Tsuneo ^a   Tajima, Yoshitsugu ^a   Harada, Mamoru ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Autophagy; Growth arrest; MDA5; Poly(I:C)

Indexed keywords

CASPASE; CYCLIN D1; CYTOPLASMIC RECEPTOR; INNATE ADJUVANT RECEPTOR; MYC PROTEIN; POLYINOSINIC POLYCYTIDYLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; BREAST CANCER; CANCER CELL; CELL CYCLE ARREST; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DRUG DELIVERY SYSTEM; DRUG TARGETING; FEMALE; FLOW CYTOMETRY; GENE; GENE ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5; MOUSE; NONHUMAN; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; AUTOPHAGY; BREAST NEOPLASMS; CASPASES; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; DEAD-BOX RNA HELICASES; DRUG CARRIERS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; POLY I-C; TOLL-LIKE RECEPTOR 3; TRANSFECTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84863989201     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1930-3     Document Type: Article

References (38)

1. K Takeda T Kaisho S Akira 2003 Toll-like receptors Ann Rev Immunol 21 335 376 10.1146/annurev.immunol.21.120601.141126 1:CAS:528:DC%2BD3sXjtF2isrg%3D
2. L Apetoh F Ghiringhelli A Tesniere, et al. 2007 Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy Nat Med 13 1050 1059 17704786 10.1038/nm1622 1:CAS:528: DC%2BD2sXhtVSgtr3E
3. Curtin JF, Liu N, Candolfi M et al (2009) HMGB1 mediates endogenous TLR2 activation and brain tumor regression. PLoS Med 13:6:e10
4. SG Park Z Jiang ED Mortenson, et al. 2010 The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity Cancer Cell 18 160 170 20708157 10.1016/j.ccr.2010.06.014 1:CAS:528:DC%2BC3cXhtVejs7vF
5. BC Bumette H Liang Y Lee, et al. 2011 The efficacy of radiotherapy relies upon induction of type I interferon-dependent innate and adaptive immunity Cancer Res 71 2488 2496 10.1158/0008-5472.CAN-10-2820
6. J Stagg S Loi U Divisekara, et al. 2011 Anti-ErbB-2 mAb therapy requires type I and II interferins and synergizes with anti-PD-1 or anti-CD137 mAb therapy Proc Natl Acad Sci USA 108 7142 7147 21482773 10.1073/pnas.1016569108 1:CAS:528:DC%2BC3MXlslyqt7w%3D
7. MG Kelly AB Alvero R Chen, et al. 2006 TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer Cancer Res 66 3859 3868 16585214 10.1158/0008-5472.CAN-05-3948 1:CAS:528:DC%2BD28XjtVOru7k%3D
8. MJ Szczepanski M Czystowska M Szajnik, et al. 2009 Triggering of toll-like receptor 4 expressed on human head and squamous cell carcinoma promotes tumor development and protects the tumor from immune attack Cancer Res 69 3105 3113 19318560 10.1158/0008-5472.CAN-08-3838 1:CAS:528: DC%2BD1MXjvVWitro%3D
9. W He Q Liu L Wang W Chen N Li X Cao 2007 TLR4 signaling promotes immune escapes of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance Mol Immunol 44 2850 2859 17328955 10.1016/j.molimm.2007.01. 022 1:CAS:528:DC%2BD2sXjtVWrtrs%3D
10. D Chiron C Pellat-Deceunynck M Maillasson R Bataille G Jego 2009 Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis J Immunol 183 4371 4377 19734228 10.4049/jimmunol. 0901436 1:CAS:528:DC%2BD1MXhtFGjs7fO
11. Z Cai A Sanchez Z Shi T Zhang M Liu D Zhang 2011 Activation of toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth Cancer Res 71 2466 2475 21427357 10.1158/0008-5472.CAN-10-1993 1:CAS:528:DC%2BC3MXktVOjt7Y%3D
12. T Morikawa A Sugiyama H Kume, et al. 2007 Identification of toll-like receptor 3 as a potential therapeutic target in clear renal cell carcinoma Clin Cancer Res 13 7503 7509 10.1158/1078-0432.CCR-07-0603
13. B Salaun S Lebecque S Matikainen D Rimoldi P Romero 2007 Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 13 4565 4574 17671143 10.1158/1078-0432.CCR-07-0274 1:CAS:528: DC%2BD2sXotlGqu7g%3D
14. B Salaun I Coste MC Rissoan SJ Lebecque T Renno 2006 TLR3 can directly trigger apoptosis in human cancer cells J Immunol 176 4894 4901 16585585 1:CAS:528:DC%2BD28XjtV2gtr0%3D
15. B Salaun L Zitvogel C Asselin-Paturel, et al. 2011 TLR3 as a biomarker for the therapeutic efficacy of double-stranded RNA in breast cancer Cancer Res 71 1607 1614 21343393 10.1158/0008-5472.CAN-10-3490 1:CAS:528: DC%2BC3MXisFCnsrw%3D
16. M Matsumoto T Seya 2008 TLR3: interferon induction by double-strand RNA including poly(I:C) Adv Drug Delivery Rev 60 805 812 10.1016/j.addr.2007.11.005 1:CAS:528:DC%2BD1cXksVagsL8%3D
17. H Kato O Takeuchi S Sato, et al. 2006 Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses Nature 441 101 105 16625202 10.1038/nature04734 1:CAS:528:DC%2BD28XktVGltLk%3D
18. D Tormo A Checinska D Alonso-Curbelo, et al. 2009 Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells Cancer Cell 16 103 114 19647221 10.1016/j.ccr.2009.07.004 1:CAS:528:DC%2BD1MXhsVCjsrfK
19. R Besch H Poeck T Hohenauer, et al. 2009 Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells J Clin Invest 119 2399 2411 19620789 1:CAS:528: DC%2BD1MXpsFCksr0%3D
20. DA Gewirtz 2009 Autophagy, senescence and tumor dormancy in cancer therapy Autophagy 5 1232 1234 19770583 10.4161/auto.5.8.9896
21. CD Buckley D Pilling NV Henriquez, et al. 1999 RGD peptides induce apoptosis by direct caspase-3 activation Nature 397 534 539 10028971 10.1038/17409 1:CAS:528:DyaK1MXhtlCkurs%3D
22. B Levine G Kroemer 2008 Autophagy in the pathogenesis of diseases Cell 132 27 42 18191218 10.1016/j.cell.2007.12.018 1:CAS:528:DC%2BD1cXhtFehtb8%3D
23. Y Kabeya N Mizushima T Ueno, et al. 2000 LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing EMBO J 19 5720 5728 11060023 10.1093/emboj/19.21.5720 1:CAS:528:DC%2BD3cXovFaiurk%3D
24. XH Liang S Jackson M Seaman K Brown B Kempkes H Hibshoosh B Levine 1999 Induction of autophagy and inhibition of tumorigenesis by beclin 1 Nature 402 672 676 10604474 10.1038/45257 1:CAS:528:DC%2BD3cXjslek
25. F Ghiringhelli L Apetoh F Housseau G Kroemer L Zitvogel 2007 Links between innate and cognate tumor immunity Curr Opin Immunol 19 224 231 17303400 10.1016/j.coi.2007.02.003 1:CAS:528:DC%2BD2sXislehsrw%3D
26. E Ullrich C Menard C Flament, et al. 2008 Dendritic cells and innate defense against tumor cells Cytokine Growth Factor Rev 19 79 92 18155952 10.1016/j.cytogfr.2007.10.009 1:CAS:528:DC%2BD1cXhsleksb4%3D
27. W Barchet V Wimmenauer M Schlee G Hartman 2008 Accessing the therapeutic potential of immunostimulatory nucleic acids Curr Opin Immunol 20 389 395 18652893 10.1016/j.coi.2008.07.007 1:CAS:528:DC%2BD1cXpslSlsbk%3D
28. T Ebihara M Azuma H Oshiumi, et al. 2010 Identification of polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation J Exp Med 207 2675 2687 21059856 10.1084/jem.20091573 1:CAS:528:DC%2BC3cXhsFWitLfE
29. K Hirabayashi J Yano T Inoue, et al. 1999 Inhibition of cancer cell growth by polyinosinic-polycytidylic acid/cationic liposome complex: a new biological activity Cancer Res 59 4325 4333 10485480 1:CAS:528: DyaK1MXlvVSms7c%3D
30. S Peng J Geng R Sun Z Tian H Wei 2009 Polyinosinic-polycytidylic acid liposome induces human hepatoma cells apoptosis which correlates to the up-regulation of RIG-I like receptors Cancer Sci 100 529 536 19154402 10.1111/j.1349-7006.2008.01062.x 1:CAS:528:DC%2BD1MXjt1WrtbY%3D
31. Harashima N, Inao T, Imamura R, Okano S, Suda T, Harada M (2012) Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells. Cancer Immunol Immunother (in press)
32. RC Muise-Hemericks H Grimes A Bellacosa SE Malstrom PN Tsichlis N Rosen 1998 Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Ae-dependent pathway J Biol Chem 273 29864 29872 10.1074/jbc.273.45.29864
33. U Akar A Chaves-Reyz M Barrio, et al. 2008 Silencing Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells Autophagy 4 669 679 18424910 1:CAS:528:DC%2BD1cXpsVCktLs%3D
34. N Mujumdar TN Mackenzie V Dudeja, et al. 2010 Triptolide induces cell death in pancreatic cancer cells by apoptotic and autophagic pathways Gastroenterology 139 598 608 20434451 10.1053/j.gastro.2010.04.046 1:CAS:528:DC%2BC3cXpsVGms7c%3D
35. L Bonapace BC Bornhauser M Schmitz, et al. 2010 Induction of autophagy-dependent necrosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance J Clin Invest 120 1310 1323 20200450 10.1172/JCI39987 1:CAS:528:DC%2BC3cXksVChtr4%3D
36. KN Dalby I Takedareli G Lopez-Berestein B Ozpolat 2010 Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer Autophagy 6 322 329 20224296 10.4161/auto.6.3.11625 1:CAS:528:DC%2BC3cXpt1WjtLw%3D
37. W Hou J Han C Lu LA Goldstein H Rabinowich 2010 Autophagic degradation of active caspase-8. A crosstalk mechanism between autophagy and apoptosis Autophagy 6 891 900 20724831 10.4161/auto.6.7.13038 1:CAS:528:DC%2BC3cXhtl2ksr7F
38. Y Yang D Xing F Zhou Q Chen 2010 Mitochondrial autophagy protects against heat shock-induced apoptosis through reducing cytosolic cytochrome c release and downstream caspase-3 Biochem Biophys Rres Commun 395 190 195 10.1016/j.bbrc.2010.03.155 1:CAS:528:DC%2BC3cXlsFGgt70%3D